- Tytuł:
- Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study
- Autorzy:
- Źródło:
-
Advances in Therapy . 35(8):1153-1168
Czasopismo naukowe